AR226285A1 - Procedimiento para la preparacion de 2-aril-aminotiazoles y sus sales de adicion de acidos farmaceuticamente aceptables - Google Patents

Procedimiento para la preparacion de 2-aril-aminotiazoles y sus sales de adicion de acidos farmaceuticamente aceptables

Info

Publication number
AR226285A1
AR226285A1 AR276782A AR27678279A AR226285A1 AR 226285 A1 AR226285 A1 AR 226285A1 AR 276782 A AR276782 A AR 276782A AR 27678279 A AR27678279 A AR 27678279A AR 226285 A1 AR226285 A1 AR 226285A1
Authority
AR
Argentina
Prior art keywords
aminotiazoles
aryl
procedure
preparation
pharmaceutically acceptable
Prior art date
Application number
AR276782A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR226285A1 publication Critical patent/AR226285A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B15/00—Nails; Staples
    • F16B15/0023—Nail plates
    • F16B2015/0076—Nail plates with provisions for additional fastening means, e.g. hooks, holes for separate screws or nails, adhesive

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR276782A 1978-06-02 1979-06-01 Procedimiento para la preparacion de 2-aril-aminotiazoles y sus sales de adicion de acidos farmaceuticamente aceptables AR226285A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91183078A 1978-06-02 1978-06-02

Publications (1)

Publication Number Publication Date
AR226285A1 true AR226285A1 (es) 1982-06-30

Family

ID=25430923

Family Applications (1)

Application Number Title Priority Date Filing Date
AR276782A AR226285A1 (es) 1978-06-02 1979-06-01 Procedimiento para la preparacion de 2-aril-aminotiazoles y sus sales de adicion de acidos farmaceuticamente aceptables

Country Status (36)

Country Link
JP (1) JPS5936988B2 (fr)
AR (1) AR226285A1 (fr)
AT (1) AT373248B (fr)
AU (1) AU511242B2 (fr)
BE (1) BE876732A (fr)
CA (1) CA1117949A (fr)
CH (1) CH639653A5 (fr)
CS (1) CS216927B2 (fr)
DD (1) DD144055A5 (fr)
DE (1) DE2922523C2 (fr)
DK (1) DK150068C (fr)
EG (1) EG14354A (fr)
ES (1) ES481220A1 (fr)
FI (1) FI68820C (fr)
FR (1) FR2427333A1 (fr)
GB (1) GB2022085B (fr)
GR (1) GR73142B (fr)
HK (1) HK66487A (fr)
HU (1) HU180045B (fr)
IE (1) IE48426B1 (fr)
IL (1) IL57450A (fr)
IT (1) IT1121238B (fr)
KE (1) KE3459A (fr)
LU (1) LU81349A1 (fr)
MY (1) MY8500318A (fr)
NL (1) NL178421C (fr)
NO (1) NO150760C (fr)
NZ (1) NZ190623A (fr)
PH (1) PH17020A (fr)
PL (1) PL117515B1 (fr)
PT (1) PT69718A (fr)
SE (1) SE438333B (fr)
SG (1) SG56184G (fr)
SU (1) SU843746A3 (fr)
YU (1) YU40997B (fr)
ZA (1) ZA792729B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001481A1 (fr) * 1980-10-24 1982-05-13 Ronald P Hansen Systeme de reduction de la poussiere
EP0068033B1 (fr) * 1981-01-08 1985-07-10 Mitsui Toatsu Kagaku Kabushiki Kaisha Derives de n-(4-phenyl-2-thiazolyl)carbamate, procede de preparation et composition medicinale les contenant
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
US4501750A (en) * 1981-01-13 1985-02-26 Mitsui Toatsu Kaguku Kabushiki Kaisha Thiazole compounds, a process for preparing same and a pharmaceutical composition containing the thiazole compounds
WO1982002386A1 (fr) * 1981-01-13 1982-07-22 Sakano Isao Derives d'aminothiazoles, procede de preparation et composition medicinale les contenant
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
DE3227329A1 (de) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen
WO1986003203A1 (fr) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
JPS63152368A (ja) * 1986-06-03 1988-06-24 Sumitomo Pharmaceut Co Ltd 新規なアミノアゾ−ル誘導体およびその酸付加塩
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
ES2111540T3 (es) * 1989-08-10 1998-03-16 Commw Scient Ind Res Org Metodo para la produccion de una electrosuspension de microparticulas.
WO1992015570A1 (fr) * 1991-03-07 1992-09-17 Hisamitsu Pharmaceutical Co., Inc. Nouveau derive de diphenylthiazole
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
WO1996003392A1 (fr) * 1994-07-27 1996-02-08 G.D. Searle & Co. Thiazoles substitues destines au traitement de l'inflammation
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
AU2001237401B2 (en) 2000-03-01 2006-11-09 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
WO2003015777A1 (fr) * 2001-08-13 2003-02-27 Lion Bioscience Ag Composes de liaison au recepteur nucleaire nr1h4
WO2003027100A1 (fr) * 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Inhibiteurs de lyase c17,20 a base de 3-pyridyle-pyrimidine substituee
CA2473461C (fr) 2002-01-11 2011-11-01 Sankyo Company, Limited Derive d'amino-alcool ou derive d'acide phosphonique et composition medicamenteuse les contenant
EP1555264A1 (fr) * 2004-01-15 2005-07-20 Sireen AG Hétérocycles à cinq chaínons comme inhibiteurs de la famille des SRC proteines kinases
BRPI0507944A (pt) 2004-02-24 2007-07-24 Sankyo Co composição farmacêutica
AU2006244203B2 (en) 2005-05-09 2012-05-03 Achillion Pharmaceuticals, Inc. Thiazole compounds and methods of use
AU2007207743B2 (en) 2006-01-18 2010-07-08 Amgen Inc. Thiazole compounds as protein kinase B (PKB) inhibitors
WO2009011871A2 (fr) 2007-07-17 2009-01-22 Amgen Inc. Thiadiazoles modulateurs de l'activité de pkb
CA2692713A1 (fr) 2007-07-17 2009-01-22 Amgen Inc. Modulateurs heterocycliques de pkb
US20130143927A1 (en) * 2011-06-10 2013-06-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2012170931A2 (fr) 2011-06-10 2012-12-13 Calcimedica, Inc. Composés qui modulent le calcium intracellulaire
WO2013059677A1 (fr) 2011-10-19 2013-04-25 Calcimedica, Inc. Composés qui modulent le calcium intracellulaire
CN110590785B (zh) * 2019-09-23 2021-02-02 武汉大学 一种氨基噻唑类化合物及其制备方法与抗肠道病毒71型的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458526A (en) * 1966-09-26 1969-07-29 Upjohn Co Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles

Also Published As

Publication number Publication date
IE48426B1 (en) 1985-01-23
PH17020A (en) 1984-05-11
BE876732A (fr) 1979-12-03
FI68820C (fi) 1985-11-11
JPS54160369A (en) 1979-12-19
LU81349A1 (fr) 1979-12-07
EG14354A (en) 1984-06-30
NO150760C (no) 1984-12-12
YU128879A (en) 1982-10-31
GB2022085B (en) 1983-01-12
IT7923228A0 (it) 1979-06-01
NO791831L (no) 1979-12-04
NZ190623A (en) 1984-07-06
HU180045B (en) 1983-01-28
IT1121238B (it) 1986-03-26
HK66487A (en) 1987-09-25
DD144055A5 (de) 1980-09-24
DE2922523C2 (de) 1982-10-21
GB2022085A (en) 1979-12-12
NL178421C (nl) 1986-03-17
DE2922523A1 (de) 1979-12-06
KE3459A (en) 1984-10-12
AU511242B2 (en) 1980-08-07
YU40997B (en) 1986-10-31
NO150760B (no) 1984-09-03
DK150068C (da) 1987-06-29
DK150068B (da) 1986-12-01
FI791754A (fi) 1979-11-26
CH639653A5 (fr) 1983-11-30
ATA401679A (de) 1983-05-15
GR73142B (fr) 1984-02-09
SG56184G (en) 1985-03-08
SE7904798L (sv) 1979-12-03
MY8500318A (en) 1985-12-31
PL117515B1 (en) 1981-08-31
PT69718A (en) 1979-07-01
CA1117949A (fr) 1982-02-09
NL7904337A (nl) 1979-12-04
AU4763479A (en) 1979-12-06
PL216030A1 (fr) 1980-03-10
SU843746A3 (ru) 1981-06-30
FR2427333B1 (fr) 1983-05-20
IL57450A0 (en) 1979-09-30
SE438333B (sv) 1985-04-15
ZA792729B (en) 1981-03-25
FR2427333A1 (fr) 1979-12-28
AT373248B (de) 1983-12-27
CS216927B2 (en) 1982-12-31
DK177679A (da) 1979-12-03
IE791069L (en) 1979-12-02
IL57450A (en) 1982-11-30
ES481220A1 (es) 1980-09-01
FI68820B (fi) 1985-07-31
JPS5936988B2 (ja) 1984-09-06
NL178421B (nl) 1985-10-16

Similar Documents

Publication Publication Date Title
AR226285A1 (es) Procedimiento para la preparacion de 2-aril-aminotiazoles y sus sales de adicion de acidos farmaceuticamente aceptables
ES494590A0 (es) Procedimiento para la preparacion de derivados de acidos b- carbolin-3-carboxilicos
MX6749E (es) Procedimiento para la preparacion de derivados de tetrazolilalcoxicarboestirilo
AR222828A1 (es) Procedimiento para la preparacion de 2,3,4,5-tetrahidro-6-feniltio-1h-3-benzazepinas y sus sales
AR229103A1 (es) Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales
MX5676E (es) Procedimiento mejorado para la preparacion de cicloalcanoles y cicloalcanonas
MX5629E (es) Procedimiento para la preparacion de esteres insaturados de los acidos 4-(3',5'-dihalogenpiridil-(2')-oxi)-alfa fenoxipropionico y tiopropionico
ES494668A0 (es) Procedimiento para la preparacion de sales de la (+)-cate- quina
ES495977A0 (es) Un procedimiento para la preparacion de derivados acidos penem-carboxilicos
ES506222A0 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
ES494989A0 (es) Procedimiento para la preparacion de derivados de aminoaci- dos
MX5375E (es) Procedimiento para la preparacion de n-(diaminofosfinil)-arilcarboxamidas
AR221355A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil y pirrolidinilmetil-benzamidas
AR225653A1 (es) Un procedimiento para la preparacion de derivados de n-(2-fenil-2-hidroxietil)-1-metil-3-fenil-propilamina y sus sales
AR212468A1 (es) Procedimiento para la preparacion de nuevos derivados de w-alquilamidas de acidos w amino-carboxilicos y sus sales
AR215162A1 (es) Procedimiento mejorado para la preparacion de acido d,1-5-metiltetrahidrofolico y sus sales
MX4841E (es) Procedimiento para la preparacion de 2-bromo-6-fluor-n-2-imidazolidiniliden-benzamina y sus sales por adicion de acido
MX150180A (es) Procedimiento mejorado para la preparacion de acidos glioxilicos y sus derivados
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
AR231543A1 (es) Procedimiento para preparar esteres de acido 3-metilflavon-8-carboxilio y sus sales farmaceuticamente aceptables
ES492243A0 (es) Procedimiento para la preparacion de acido 4,4'dinitro es- tilben-2,2'-disulfonico y sus sales
MX5632E (es) Procedimiento mejorado para la preparacion de levo n-(1-etil-2-pirrolidinometil)-2-metoxi-5-sulfamoilbenzamida
ES490995A0 (es) Procedimiento para la preparacion de derivados de uretano
AR214985A1 (es) Procedimiento para la elaboracion de 4-7-bromo-5-metoxi-2-benzofuranil)-piperidina y sus sales de adicion de acidos
MX3845E (es) Procedimiento para la preparacion de sulfoximidas substituidas y sus sales